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Monoallelic expression of imprinted genes, including ones solely expressed in the placenta, is essential
for normal placental development and fetal growth. To better understand the role of placental
imprinting in placental development and fetal growth, we examined conceptuses developing in the
absence of maternally derived DNA (cytosine-5-)-methyltransferase 1o (DNMT1o). Absence of DNMT1o
results in the partial loss of methylation at imprinted differentially methylated domain (DMD)
sequences in the embryo and the placenta. Mid-gestation E9.5 DNMT1o-deﬁcient placentas exhibited
structural abnormalities of all tissue layers. At E17.5, all examined placentas had aberrant placental
morphology, most notably in the spongiotrophoblast and labyrinth layers. Abnormalities included an
expanded volume fraction of spongiotrophoblast tissue with extension of the spongiotrophoblast layer
into the labyrinth. Many mutant placentas also demonstrated migration abnormalities of glycogen
cells. Additionally, the volume fraction of the labyrinth was reduced, as was the surface area for
maternal fetal gas exchange. Despite these placental morphologic abnormalities, approximately one-
half of DNMT1o-deﬁcient fetuses survived to late gestation (E17.5). Furthermore, DNMT1o-deﬁcient
placentas supported a broad range of fetal growth. The ability of some DNMT1o-deﬁcient and
morphologically abnormal placentas to support fetal growth in excess of wild type demonstrates the
importance of differential methylation of DMDs and proper imprinting of discrete gene clusters to
placental morphogenesis and fetal growth.
& 2012 Elsevier Inc. All rights reserved.Introduction
Genomic imprinting is a highly conserved epigenetic process
that distinguishes parental alleles of a small number of genes
such that only one parental allele is transcriptionally active. For
the majority of imprinted genes, this difference is absolute; one
allele is expressed and the opposite allele is silent (Bartolomei
and Tilghman, 1997). With few exceptions, the approximately
100 known mouse imprinted genes are organized into 16 clusters
(http://www.mousebook.org/catalog.php?catalog=imprinting.)
harboring a variable number of imprinted genes. Importantly, the
imprinted, monoallelic expression of genes in the same cluster is
determined by a small contiguous set of sequences called the
imprint control region (ICR) (Reinhart et al., 2002). In general,
deletion of ICR sequences leads to complete (biallelic) transcrip-
tional silencing or to biallelic expression, depending on the
cluster and the particular gene in the cluster. These ﬁndings
are consistent with the notion that imprinted gene expression
is a complex regulatory phenomenon involving many cis- andll rights reserved.
haillet).trans-acting factors, but mediated primarily through ICRs (Reinhart
and Chaillet, 2005).
The function of ICR sequences in regulating the imprinted
expression of genes appears to be largely determined by differ-
entially methylated domains (DMDs) within the ICR sequence.
DMDs originate during gametogenesis through the action of DNA
(cytosine-5-)-methyltransferase 3 alpha (Bourc’his et al., 2001;
Hata et al., 2002; Kaneda et al., 2004). After fertilization, DMD
methylation is maintained in all cells of the conceptus by
different isoforms of the DNMT1 cytosine-5 methyltransferase
(Cirio et al., 2008a; Hirasawa et al., 2008).
Proper inheritance of methylation imprints is essential for
normal development. Insight into the mechanism of this epigenetic
inheritance during preimplantation has come from examining the
expression of isoforms of DNMT1. The enzyme DNMT1o exhibits a
unique, stage-speciﬁc role in the inheritance of DMD methylation
during preimplantation. DNMT1o is synthesized in the maternal
oocyte and maintains DMD methylation in the 8-cell embryo (Cirio
et al., 2008b; Doherty et al., 2002; Howell et al., 2001). In contrast
the longer somatic DNMT1s form maintains methylation at other
preimplantation cleavage stages (Cirio et al., 2008a; Hirasawa
et al., 2008). Post-implantation embryos derived from DNMT1o-
deﬁcient oocytes have lost methylation on 50% of the normally
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generation of epigenetic mosaic embryos (Cirio et al., 2008b;
Howell et al., 2001; Toppings et al., 2008). These are produced by
the combined effects of a loss of DNMT1o maintenance methyl-
transferase activity followed by the normal process of random
chromosome segregation. The loss of methylation leads to altered
expression of imprinted genes, manifest as biallelic expression of
some genes or loss of expression of most genes. Methylation of
non-imprinted DNA is unchanged.
Imprinted genes are highly and in some cases uniquely
expressed in the placenta. Of the 16 imprinted gene clusters,
seven (Peg10, H19/Igf2, Mest, Kcnq1, Grb10, Dlk1/Meg3, and Igf2r)
are of particular interest. Not only do these clusters contain genes
that are highly expressed in the placenta, but mutations in these
genes have been associated with placental maldevelopment and/
or dysfunction (Frost and Moore, 2010). For example, ablation of
the maternally expressed allele of Ascl2 results in fetal death on
embryonic day 10.5 (E10.5), with poorly developed labyrinthine
vasculature, reduced population of spongiotrophoblasts, and an
excess of trophoblast giant cells (Guillemot et al., 1994). Deletion
of Peg10 results in a similar placental phenotype (Ono et al.,
2006).
While much has been learned about the role of imprinted
genes in placental development from targeted inactivating or
over-expressing individual imprinted genes, a comprehensive
study of the role of imprinting in placental function should
include removal of the inherited DNA methylation at DMD
sequences. This can be conferred by DNMT1o deﬁciency. The loss
of DNMT1o in embryos from homozygous Dnmt1D1o/D1o female
mice provides an opportunity to analyze the functions of multiple
imprinted genes by stochastic elimination of DMD methylation at
many sites. Here we tested the hypothesis that DNMT1o deﬁ-
ciency adversely affects placental development and function.Materials and methods
Animals
The mutant Dnmt1D1o allele was maintained in the wild type
(wt) 129/SvTac strain background. Embryos derived from wild-
type and homozygous Dnmt1D1o/D1o dams mated with 129/SvTac
males were compared. For studies of parent-speciﬁc methylation
of differentially methylated domains (DMDs), Dnmt1D1o/D1o or wt
129/Sv/Tac female mice were crossed to inbred CAST/Ei male
mice. Dnmt1D1o mice were genotyped using a PCR assay as
previously described (Howell et al., 2001). Primers are included
in Supplemental Table 2. All experiments were performed in
compliance with guidelines established by the Institutional Ani-
mal Care and Use Committee of the University of Pittsburgh.
Placenta dissection and extraction
Copulation was determined by the presence of a vaginal plug
and embryonic day zero (E0) was assumed to be midnight.
Conceptuses were collected from the uteri of female mice at E9.5,
E12.5, E15.5 or E17.5. Placentas for DNA and RNA extraction were
dissected from embryos, decidua and yolk sac tissue and kept
individually in RNALater (Sigma). Placentas for histologic and
morphometric analyses were dissected from embryo and yolk sac
but decidua was preserved.
Determinations of DMD methylation
Genomic DNA was extracted from E9.5 and 12.5 placentas
using AllPrep DNA/RNA Micro Kit and from one half of sagittalsections of E15.5 and E17.5 using AllPrep DNA/RNA Mini Kit
(Qiagen). Genomic DNA methylation patterns of DMDs in F1
hybrid mice obtained from crosses between 129/Sv/Tac female
mice and CAST/Ei male mice were determined using the method
of bisulﬁte genomic sequencing (Lucifero et al., 2002). Five
DNMT1o-deﬁcient E9.5 placentas and six DNMT1o-deﬁcient
E17.5 placentas were analyzed. Maternal and paternal alleles
were distinguished by single nucleotide polymorphisms in the
different DMDs. Primers are included in Supplemental Table 2. For
more widespread quantitative methylation analysis the EpiTYPER
application (Sequenom) was used as previously described (Ehrich
et al., 2005). DNA methylation standards (0, 50, and 100%) were
used to correct for bias. Primers for the EpiTYPER experiments are
included in Supplemental Table 2.
Standard histology and stereology
Placentas were collected, bisected in the midline and half of
placenta ﬁxed overnight at 4 1C in 4% paraformaldehyde (PFA) in
PBS. Specimens were then dehydrated and embedded in parafﬁn.
Sections (5 mm) were stained with either hematoxylin and eosin
or periodic acid-Schiff (PAS) stain. Volume fraction of spongio-
trophoblast and labyrinth was determined by counting points
that fell in the relevant placental layer compared to total
placental reference space. Data is presented as percent spongio-
trophoblast or labyrinth of total. Four wild type (2 litters) and
twelve DNMT1o-deﬁcient placentas from 5 litters were evaluated.
RNA in situ hybridization (ISH)
E9.5 and E17.5 placentas were dissected in PBS and ﬁxed
in fresh 4% PFA. PFA-ﬁxed samples were immersed in 10%, then
20% sucrose in PBS, followed by OCT embedding. We used
digoxigenin-labeled cRNA probes, synthesized using digoxigenin
RNA labeling kit (Roche, Basel, Switzerland). Cryosections (10 mm)
of the OCT-embedded placentas were used for ISH as previously
described (Barak et al., 1999).
Immunohistochemistry
Sections (5 mm) were obtained after ﬁxing placentas in 4% PFA
overnight, dehydration and parafﬁn embedding. Immunohistochem-
istry was performed using the Vectastain Elite ABC kit (Vector
laboratories) and DAB substrate per manufacturer recommendations
(Vector Labs). To identify fetal endothelium, a 1:200 dilution of rabbit
polyclonal anti-CD31 antibody (Abcam-ab28364) was used. Hema-
toxylin and acid alcohol were used for counter stain. The ratio of
vasculature surface area to labyrinthine volume was determined
using a cycloid arc grid as previously described (Baddeley et al.,
1986; Coan et al., 2004). A cycloid arc grid was overlaid on high-
magniﬁcation images of CD31 stained sagittal placental sections from
wt or DNMT1o-deﬁcient placentas. Cycloid line intersections with
vascular walls were counted to determine vasculature surface area
and points within the reference space counted to determine volume.
Measurements were performed on systematic random samples of
24 images per placenta using every ﬁfth section from each placenta.
Five wt and 10 DNMT1o-deﬁcient placentas were analyzed. The data
are presented as maternal and fetal surface area, and expressed as
vasculature surface area per volume of labyrinth (cm2/cm3).
Quantitative measurements of imprinted gene transcripts
RNA was extracted using either the AllPrep DNA/RNA Micro or
Mini Kit (Qiagen). Contaminating DNA was removed by DNAse
treatment according to manufacturer’s instruction. Complemen-
tary DNA was prepared from 1 mg RNA using the high capacity
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was performed in triplicate using SYBR Green PCR Master Mix
(Applied Biosystems) in total reaction volume of 10 ml on the
7900HT Fast Real-Time PCR System machine. Primer pairs are
listed in Supplementary Table 2. Primer sequences were obtained
from Primer Bank or designed using Primer Express. Dissociation
curves were run on all reactions to ensure ampliﬁcation of a
single product. A control without RT (- RT) was run for each
sample and a control without template (- template) was run for
each primer set. Samples were analyzed using the DDCt method.
Five wild type placentas were analyzed at each gestational age.
Microarray gene expression studies
RNA was extracted as described above. Illumina Mouse WG-6-
v2.0 Expression BeadChips were used for whole genome expression
proﬁling. After normalization mean expression values were deter-
mined and compared by t test. Adjusted p values were then
calculated to correct for multiple comparisons. Signiﬁcant genes
were deﬁned as those with an adjusted p valueo0.05. Fold changes
were calculated and the overlapping and non-overlapping genes
between the two placental phenotypes determined. Data were then
analyzed through the use of Ingenuity Pathway Analysis (IPA). IPA
Functional Analysis identiﬁed the biological functions and networks
that were most signiﬁcant among our list of genes. Right-tailed
Fisher’s exact test was used to calculate a p-value.E9.5 P
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Fig. 1. At E9.5, DNMT1o-deﬁcient placentas have variable loss of DMD methylation at H
three DNMT1o-deﬁcient placentas are shown.M¼maternal alleles. P¼paternal alleles. P
methylation at the normally methylated allele is shown with the interquartile range in p
type by Kruskal Wallis with po0.05.Statistical analysis
Kruskal Wallis was used for nonparametric univariate analysis
of continuous variables. Normality was assessed by sktest. Multi-
variable linear regression was used to assess the independent
association between E/P ratio and imprinted gene expression.
Gender and other imprinted gene expression were considered as a
potential confounder. Given a non-parametric distribution of
DMD methylation data Spearman’s rank sum was used to deter-
mine correlation between placentas. All analyses were done with
Stata version 10 (StataCorp).Results
Epigenetic mosaicism in DNMT1o-deﬁcient placentas
We previously reported a signiﬁcant loss of methylation
from normally methylated parental alleles in both the H19/Igf2
and Snurf/Snrpn DMDs of E9.5 DNMT1o-deﬁcient placentas (Cirio
et al., 2008b). We extended these ﬁndings to additional DMDs and
examined DMD methylation in late gestation. As shown in
representative placentas in Fig. 1, strict parent-speciﬁc DMD
methylation was observed for all DMDs in a wt E9.5 placenta. In
contrast, signiﬁcant deviations from parent-speciﬁc methylation
were observed in DMDs of all DNMT1o-deﬁcient placentaslacentas
tseMnprnS
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arentheses. * Denotes signiﬁcantly different methylation of CpGs compared to wild
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lation was observed in all mutant placentas. We also observed
placenta-to-placenta variation in the extent of methylation loss at
individual DMDs. For example, whereas M1 showed a pattern
of strict parent-speciﬁc methylation for Snurf/Snrpn DMD, M2
showed a near complete loss. In any individual placenta, there
was no correlation among the four different DMDs for the extent
of methylation loss. For example, M1 showed nearly complete
loss of DMD methylation on H19/Igf2 DMD and Mest DMD, yet
normal methylation on Snurf/Snrpn DMD, whereas M2 showed
nearly complete loss of DMD methylation on Mest, Snurf/Snrpn,
and Kcnq1 DMD, yet near normal methylation on H19/Igf2 DMD.
Finally, there was no evidence in wt or DNMT1o-deﬁcient
placentas of methylation on the normally unmethylated parental
allele. We conclude that DNMT1o-deﬁcient placentas are devel-
oping during the ﬁrst half of gestation as cellular mosaics with
variable loss of DMD methylation across all DMDs examined.
At E17.5, the type and extent of DMD methylation changes
were distinct from those obtained from E9.5 DNMT1o-deﬁcient
placentas (Fig. 2). For the Snurf/Snrpn and Mest DMDs, we
observed signiﬁcant loss of DMD methylation in single placentas,
with no evidence of acquisition of methylation on the normally
unmethylated parental DMD allele. For H19/Igf2 and Kcnq1 DMDs,
while the normally unmethylated parental allele remained
unmethylated in all DNMT1o-deﬁcient placentas, of the six
placentas we analyzed methylation of the normally methylatedE17.5 P
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Fig. 2. At E17.5, DNMT1o-deﬁcient placentas have variable loss of DMD methylation at
type in placentas examined. Methylation patterns of a representative wild type and thre
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parentheses. * Denotes signiﬁcantly different methylation of CpGs compared to wild typarental allele was not signiﬁcantly altered. This ﬁnding is
notably different from H19/Igf2 and Kcnq1 DMD methylation in
E9.5 DNMT1o-deﬁcient placentas. Finally, as was true at E9.5,
there was no evidence in wt or DNMT1o-deﬁcient placentas of
methylation on the normally unmethylated parental allele. We
conclude from these allele-speciﬁc DMD methylation studies that
while DMD epigenetic mosaicism is found in late gestational
DNMT1o-deﬁcient placentas, the precise makeup of mosaics
evolves during the second half of gestation such that it is
uncommon to recover certain patterns of DMD methylation.Temporal progression of imprinted-gene expression in DNMT1o-
deﬁcient placentas
To further understand the changes across gestation in
DNMT1o-deﬁcient placentas, we used quantitative RT-PCR (RT-
qPCR) to determine the expression of a large set of imprinted
genes, spanning seven imprinted clusters at E9.5, E12.5, E15.5 and
E17.5 (Fig. 3). In E9.5 DNMT1o-deﬁcient placentas, we found that
average changes in imprinted-gene expression compared to wt
levels were consistent with predictions due to changes in DMD
methylation. For example, mean H19 gene expression approxi-
mately doubled while mean Igf2 gene expression approximately
halved, as expected for a 50% loss of H19/Igf2 DMD methylation
(Cirio et al., 2008b; Howell et al., 2001). Interestingly, the proﬁlelacentas
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Fig. 3. Expression of imprinted genes from DNMT1o-deﬁcient placentas at E9.5, E12.5, E15.5 and E17.5 evolves across gestation. The histograms summarize mean
expression (þSEM) of imprinted genes from seven imprinted gene clusters in DNMT1o-deﬁcient placentas compared to wild type (n¼5). Each qPCR measurement was
performed in triplicate, normalized to the L32 gene, and analyzed with the DDCt method. (n¼number of placentas studied). * Denotes signiﬁcantly different expression
compared to wild type by Kruskal Wallis with po0.05.
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pattern seen at E9.5 suggesting that at least until E12.5, imprinted
genes are expressed in a manner consistent with their predicted
DMD methylation. In contrast, the proﬁles of imprinted-gene
expression at E15.5 and E17.5 changed dramatically (Fig. 3). For
example, at E17.5 the mean H19 and Igf2 expression levels in
DNMT1o-deﬁcient placentas were similar to wt levels. Addition-
ally, at both E15.5 and 17.5 genes within the Dlk1 and Kcnq1
clusters were increased, a ﬁnding contrary to that predicted based
on loss of methylation at the DMD. Moreover, we observed a
broad spectrum of imprinted-gene expression proﬁles among
individual E17.5 DNMT1o-deﬁcient placentas (Supplemental
Table 1).
Highly variable structures of DNMT1o-deﬁcient placentas
It is known that highly variable patterns of DMD methylation
and imprinted-gene expression observed among DNMT1o-
deﬁcient embryos are accompanied by a highly variable embryo-
nic morphology (Toppings et al., 2008). This relationship suggests
that deviation from strict parent-speciﬁc DMD methylation and
monoallelic expression leads to defects in embryonic develop-
ment. Given DNMT1o-deﬁcient placentas also had signiﬁcant
variability in DMD methylation at E9.5, we sought to determine
if DNMT1o-deﬁcient placentas were structurally abnormal early
in gestation. Using cell- and tissue-speciﬁc markers we identiﬁed
multiple structural anomalies in DNMT1o-deﬁcient placentas
compared to an E9.5 wt control (39 DNMT1o-deﬁcient placentas
analyzed). A representative litter is shown in Fig. 4. For example,
an expanded giant cell layer (Prl2c2 probe) was observed in three
out of seven mutant placentas (M1, M2 and M7). Moreover,
structural distortions of the spongiotrophoblast layer (Tpbpa)
and labyrinth (Tfeb) were common (M2–M5). Only one Dnmt1o-
deﬁcient placentas, M6, had normal morphology.To describe the spatial expression pattern of imprinted genes
in Dnmt1o-deﬁcient placentas we probed the same placentas for
expression of Ascl2, Phlda2 and Igf2 (Fig. 4). The imprinted gene
Ascl2, normally expressed in both the labyrinth and spongiotro-
phoblast, displayed variable expression in DNMT1o-deﬁcient
placentas, ranging from patchy, mosaic expression in the labyr-
inth and/or spongiotrophoblast (M3 and M4) to normal expres-
sion (M3 and M4). Phlda2 is expressed robustly in the wt
labyrinth whereas the same mutants that had loss of Ascl2
expression (M3 and M4) also had decreased Phlda2 expression.
The imprinted gene Igf2 also displayed a great deal of variation in
the mutants. In wt and two mutant (M6 and M7) placentas Igf2 is
ubiquitously expressed, with particularly high levels in the
labyrinth. Five of the mutants (M1-M5) had severely restricted
Igf2 expression as compared to wt. This data supports the notion
that Dnmt1o-deﬁcient placentas are mosaic for the expression of
imprinted genes.
Our DMD methylation and imprinted gene expression data
from E17.5 differed from our ﬁndings at E9.5. Given this we
sought to determine the impact of DNMT1o deﬁciency on fetal
viability, fetal growth, and placental morphology in late gestation
(E17.5). Table 1 demonstrates the percentage of embryos that
were alive at E9.5, E12.5, E15.5, and E17.5. At E17.5, 28/59 (from
11 litters) DNMT1o-deﬁcient fetuses were alive versus 20/20
(3 litters) wt fetuses. Despite the decline in fetal viability across
gestation, the relatively large number of fetuses recovered at
E17.5 indicates that a proportion of E9.5 mosaic placentas are
capable of further growth and development. Interestingly, as seen
in Fig. 5F and G, E17.5 DNMT1o-deﬁcient embryos and placentas
were larger than wt. When embryo to placental (E/P) weight, an
indicator of placental efﬁciency, was plotted, wt embryos clustered
tightly around a mean E/P ratio of 10.0 (Fig. 5F). Among DNMT1o-
deﬁcient conceptuses, there was signiﬁcant variation in the E/P
ratio, with a mean E/P ratio of 8.2. The fetal gender was not
Fig. 4. A broad range of morphologic and gene expression abnormalities is present in E9.5 DNMT1o-deﬁcient placentas. Hematoxylin/Eosin (H&E) staining and in situ
hybridization (ISH) of frozen sections of wt and DNMT1o-deﬁcient E9.5 conceptuses from a single litter. Multiple sections from placentas of each genotype were assessed
and representative sections are shown. Each column of sections was obtained from a single conceptus. ISH probes are listed on the left include placenta lineage markers
Prl2c2, Tpbpa and Tfeb as well as the imprinted genes Ascl2, Phlda2 and Igf2. wt¼Wild type. M¼DNMT1o-deﬁcient mutant. Scale bar 500 mM.
Table 1
Survival of embryos.
Day of analysis Number of litters Number mutants
viable per litter
Wild type Mutant
E9.5 3 5 4.6
E9.5 3 5 3.1
E15.5 3 6 2.1
E17.5 3 11 2.5
K.P. Himes et al. / Developmental Biology 373 (2013) 72–82 77signiﬁcantly related to E/P ratio in either wt or DNMT1o-deﬁcient
conceptuses. Interestingly, in the DNMT1o-deﬁcient placentas
only Ascl2 and Mest expression were signiﬁcantly (po0.01 for
both) related to the E/P ratio—Ascl2 in an inverse fashion andMest
in a direct fashion (Supplemental Fig. 1). In multivariable linear
regression modeling the expression of Ascl2 and Mest accounted
for 82% of the variance in E/P ratio among DNMT1o-deﬁcient
conceptuses. This relationship remained signiﬁcant when con-
trolling for gender (po0.001).
To gain insight into the consequence of disrupted imprinting
on placental morphology late in gestation we again used standard
histological, ISH, and immunohistochemical methods to examine
a large series of E17.5 placentas. As shown in Fig. 5A, H&E stained
sections of wt E17.5 placentas revealed organized placentas with
clearly identiﬁable layers. In contrast, the histomorphology of
representative DNMT1o-deﬁcient E17.5 placentas was widelyvariable. No DNMT1o-deﬁcient placentas with wild type mor-
phology were seen. Interestingly, fetuses within the high E/P
category possessed better organized placentas, whereas those
within the low E/P category had placentas with a disorganized
structure. The dominant DNMT1o-deﬁcient phenotype – seen in
approximately 60% of placentas with viable embryos – was
characterized by a slightly enlarged spongiotrophoblast layer
with small invaginations of spongiotrophoblast into the labyrinth
(Fig. 5A). Quantiﬁcation of the volume fraction of spongiotropho-
blast and labyrinth in wt and DNMT1o-deﬁcient (low and high E/P
ratios combined) placentas revealed an increased median
volume fraction of spongiotrophoblast and decreased labyrinth
volume in DNMT1o-deﬁcient placentas compared to wt. The
marked variation of volume fractions of the layers in DNMT1o-
deﬁcient placentas compared to wt was also evident (Fig. 5E
and F). Expression of lineage speciﬁc marker genes was not
different by E/P ratio (data not shown). Given the modest
differences in overall volume fraction of the layers this is not
surprising. Placentas with low E/P ratios (smaller embryos) had
more extensive projections of spongiotrophoblast into the labyr-
inth with a greater disorganization between the layers. Finally,
while a thickened giant cell layer was seen in some DNMT1o-
deﬁcient placentas, a consistent abnormality of the giant cell layer
was not observed (data not shown).
We then used ISH for Tpbpa expression and PAS staining to
better deﬁne the defects in the spongiotrophoblast layer
of DNMT1o-deﬁcient placentas. The expression pattern of Tpbpa
conﬁrmed the ectopic location of spongiotrophoblasts in the
Fig. 5. At E17.5, DNMT1o-deﬁcient placentas demonstrate characteristic morphologic abnormalities and have a broader distribution of embryonic/placental (E/P) weight
ratios compared to wild type. (A) H&E staining of parafﬁn-embedded placental sections at E17.5 with the labyrinth, spongiotrophoblast, and maternal decidua delineated.
(B) Scatter plot of embryonic to placental weight of E17.5 wild type and DNMT1o-deﬁcient conceptuses. (C and D) Box plots showing median values, upper and lower
quartiles and range of embryonic and placental weights among wild type and DNMT1o-deﬁcient conceptuses. (E and F) Stereologic analysis of volume fraction of
spongiotrophoblast and labyrinth depicted as box plots. Scale bars, 400 mm (A). wt¼Wild type. M¼DNMT1o-deﬁcient mutant. de¼Decidua. sp¼Spongiotrophoblast.
lb¼Labyrinth. * po0.05 by Kruskal Wallis.
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staining, the spongiotrophoblast layer of DNMT1o-deﬁcienct
placentas contained more intracytoplasmic vacuoles compared
to wt. These were PAS positive, suggesting that many of these
spongiotrophoblasts were glycogen cells (Fig. 6F and G). Interest-
ingly, placentas with lower E/P ratios (smaller embryos) had less
intracytoplasmic vacuoles and less PAS positive cells in spongio-
trophoblast layer than placentas with larger embryos (Fig. 6H vs.
Figs. 6F and G).
We used CD31 immunostaining and ISH to the leptin receptor
to further examine the structure of the labyrinth. While the
labyrinth of DNMT1o-deﬁcient placentas is larger than the labyr-
inth of wt placentas, the combined surface area of fetal endothe-
lium and maternal blood pools is less in mutant placentas
512798 cm2/cm3, than wt-7907100 cm2/cm3 (po0.01). This
lack of fetal vasculature development was evident in all placentas
(Fig. 7) but was more notable in conceptuses with a low E/P ratio
(Fig. 7I and J) compared to those with a high E/P ratio (Fig. 7G
and H).
Notably, despite the disruption of the normal architecture of
the late-gestation placentas, the observed histomorphological
abnormalities were uniform across sections. We sought to deter-
mine if the loss of DNA methylation at imprinted domains in
E17.5 placentas was also uniform. To assess this we quartered
E17.5 DNMT1o-deﬁcient placentas and characterized DNAmethylation at 5 imprinted gene clusters—H19/Igf2, Kcnq1, Mest,
Igf2r, and Gtl2- in separate quarters using the EpiTYPER applica-
tion. This demonstrated a high degree of correlation in methyla-
tion between quarters of individual placentas at all ﬁve imprinted
loci (Supplementary Fig. 2).
Deﬁciency of DNMT1o induces transcriptional changes
We used gene expression microarrays to identify differences
in gene expression between DNMT1o-deﬁcient placentas with
high and low E/P ratios (n¼4 for each group). The dendrogram in
Fig. 8A shows that each group clustered together and that high
E/P placentas were more similar in patterns of gene expression to
wt placentas than the low E/P placentas. To identify biologically
meaningful genes between placental phenotypes, only genes with
a false discovery rate (FDR/q-value)o0.05 were considered sig-
niﬁcant. Data were then analyzed with Ingenuity Pathway Ana-
lysis (IPA). As seen in Fig. 8B, there was signiﬁcant overlap
between both placental phenotypes among down-regulated
genes, with at least 75% of the genes down-regulated 1.3 fold in
high E/P ratio placentas also down-regulated in low E/P ratio
placentas. Functional analysis with IPA identiﬁed genes involved
in the oxidative stress response as commonly down-regulated
genes. Less overlap was seen among genes that were up regulated
in both phenotypes. Among genes that were up-regulated in both
Fig. 6. At E17.5, DNMT1o-deﬁcient placentas had abnormal spongtotrophoblast
layer and glycogen cell distribution. (A–D) ISH with Tpbpa in representative wild
type and DNMT1o-deﬁcient placentas. (E–H) PAS staining localizes glycogen
staining largely to maternal decidua in wild type placentas. DNMT1o-deﬁcient
placentas have abnormal accumulation of glycogen in spongiotrophoblasts. This is
prominent in most placentas examined (F and G) but less notable in other
placentas (H). de¼Decidua. sp¼Spongiotrophoblast. lb¼Labyrinth. Scale bar
(A–D) 400 mm, (E–H) 400 mm (left panel) and 100 mm (right panel).
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lipid metabolism, speciﬁcally genes regulating the accumulation
of lipids. Among genes that were up regulated only in placentas
with high E/P ratio both transport of small molecules and lipids.
(Fig. 8C). Importantly, these transcriptional ﬁndings likely reﬂect
both the loss of imprinting in DNMT1o-deﬁcient placentas as well
as the change in cellular demographics due to altered placental
structure in DNTM1o mutants.Fig. 7. The labyrinth layer in DNMT1o-deﬁcient placentas at E17.5 has both
abnormal fetal vasculature and maternal blood pools. (A–E) ISH with Leptin
receptor in representative wild type and DNMT1o-deﬁcient placentas. Leptin
receptor is present in the trophoblasts that line the maternal blood pools. (F–J)
Immuno-staining with CD31 in wild type and DNMT1o-deﬁcient placentas.
* Maternal blood pools that are dilated in DNMT1o-deﬁcient placentas. Scale bar
(A–E) 400 mm (F–J) 50 mm.Discussion
Stochastic elimination of DMD methylation at many sites
during preimplantation development has a profound impact on
placental development and fetal growth that evolves across
gestation. At E9.5 the majority of embryos are alive and a broad
range of placental abnormalities are seen. By E17.5 there is a
decline in fetal viability and among surviving embryos a broad
range of fetal weights and E/P ratios are seen. Furthermore, while
placental morphology is always abnormal at E17.5, the range of
abnormalities is narrower than that seen at E9.5. These changes in
placental morphology and fetal weight parallel signiﬁcant
changes in DMD methylation and expression in imprinted genes.
At E9.5 loss of DMD methylation is seen at all DMDs we
examined. In contrast, at E17.5 among the placentas we exam-
ined, statistically signiﬁcant loss of methylation is not seen at
either the H19 or Kcnq1 DMDs. The expression of imprinted genes
also changes across gestation. At E9.5 imprinted gene expression
largely mirrors the expression one would predict based on loss of
DMD methylation. At E15.5 and E17.5, however, we observe
imprinted gene expression that is contrary to expectations based
on loss of methylation. We speculate that these ﬁndings reﬂect
changes in the cellular demographics of the placenta or signiﬁcantattrition and/or acceleration of growth of certain cells with
particular DMD methylation patterns—or epigenotypes. The
range of morphologic abnormalities we see at E9.5 compared to
E17.5 may also reﬂect a greater diversity of epigenotypes at E9.5.
Finally, the changes in proﬁles of imprinted-gene expression
across the later half of gestation, particularly the changes
between E12.5 and E15.5, suggests that expression of imprinted
genes is governed by factors other than the methylation of its
controlling DMD.
The kinship or parental conﬂict hypothesis is the most widely
accepted hypothesis to explain the evolution of imprinted genes
Fig. 8. Shared and distinct gene expression patterns are present in E17.5 DNMT1o-deﬁcient placentas with distinct E/P ratios. (A) Dendrograms describing genome-wide
expression differences in E17.5 placentas. The X-axis is 1 minus the correlation coefﬁcient. The E17.5 DNMT1o-deﬁcient placentas were pooled into two groups based on
the ratio of embryo/placental weight ratio (E/P) ratio with 4 placentas in each group. (B) Venn diagrams show the proportion of over-lapping and distinct genes that are
down or up regulated in placentas with either a high E/P ratio or a low E/P ratio. Genes were included for consideration at a qo0.05. Data are stratiﬁed by fold changes,
2.0 (top), 1.5 (middle), and 1.3 (lower). (C) Gene lists show results of functional analysis performed using Ingenuity Pathway Analysis. P value was less 0.01 for all genes in
the functional analysis.
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balance maternal and paternal contributions to fetal growth.
Consistent with the parental conﬂict hypothesis, the majority of
paternally expressed genes promote fetal growth maximizing the
reproductive ﬁtness of offspring. In contrast, maternally
expressed genes tend to restrict fetal growth allowing for off-
spring survival, but minimizing the resource drain to the mother
who will reproduce again in the future. Given this general model,
a widespread disruption of imprints during preimplantation
development would be predicted to widen the distribution of
fetal weights. Our ﬁndings are consistent with this (Fig. 5F).
Embryos that develop in the absence of DNMT1o display a broad
range of fetal weights suggesting that important checks on
establishing a normal range of fetal growth have been disturbed.
Dissecting the mechanisms underlying the different sizes of these
fetuses will improve our understanding of determinants of fetal
growth- both fetal growth restriction as well as fetal macrosomia.
How might defects in placental imprinting in DNMT1o-
deﬁcient placentas contribute to fetal weight? In the case of small
embryos (low E/P ratio), the poor fetal growth likely reﬂects both
abnormal placental development as well as abnormal placental
function. DNMT1o-deﬁcient placentas have a reduced labyrinth
zone and poor fetal vasculature development. This likely reducesthe functional surface area available for maternal-fetal exchange
of gases and nutrients. Additionally, most DNMT1o-deﬁcient
placentas have spongiotrophoblast tissue within the labyrinth
layer. This may reﬂect a migration defect of the spongiotropho-
blasts during development or a primary labyrinthine defect that
led the spongiotrophoblast to proliferate in an ectopic location.
Regardless, this contributes to the reduction in size of the
labyrinth layer seen in these placentas. The ﬁnding of glycogen
cells in the ectopic spongiotrophoblast tissue may have further
implications for fetal growth. Glycogen cells migrate to the
maternal decidua late in gestation and are thought to be a
potential source of easily available glucose for the fetus late in
gestation (Coan et al., 2006). Thus the mislocalization of glycogen
cells in the labyrinth may limit extraembyronic energy stores late
in gestation and impact fetal growth.
The glycogen cell phenotype seen in DNMT1o-deﬁcient pla-
centas is similar to that seen when Phlda2 is overexpressed
(Tunster et al., 2010). In this investigation, fetal growth restriction
developed late in gestation and the junctional zone was reduced.
In contrast, in DNMT1o-deﬁcient placentas the junctional zone is
expanded. This ﬁnding may be particularly critical because
despite disorganized placentas, many of the DNMT1o-deﬁcient
placentas supported normal to supranormal fetal growth. Given
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may be particularly critical for regulating fetal growth in the
DNMT1o model. The junctional zone is largely responsible for the
endocrine function of the placenta and the size of junctional zone
has been related to fetal weight in some mouse strains (Tunster
et al., 2012). Additionally, our microarray analysis comparing
DNMT1o-deﬁcient placentas with low and high E/P ratios sug-
gests that lipid metabolism and transport is particularly impor-
tant in the altered E/P ratio conceptuses.
The ﬁndings from DNMT1o-deﬁcient placentas, including
placentomegaly, invaginations of spongiotrophoblasts into the
labyrinth, and abnormal fetal vasculature, are similar to the
placental phenotype from mouse interspeciﬁc hybrids (Zechner
et al., 1996, 1997, 2004, Duselis and Vrana, 2010). A number of
post-zygotic mechanisms lead to reproductive isolation in inter-
speciﬁc hybridization, including placental dysplasia. Furthermore,
disruption of genomic imprinting contributes to the placental
dysplasia in interspeciﬁc hybridizaiton (Zechner et al., 2004; Shi
et al., 2005). Given the similarity in placental phenotypes
between DNMT1o-deﬁcient placentas and those from interspeci-
ﬁc hybrids it is possible that altered function of DNMT1o
contributes to post-zygotic reproductive isolation in interspeciﬁc
crosses.
Overall, our ﬁndings of wide-ranging E/P ratios in DNMT1o-
deﬁcient conceptuses also support the idea that a subset of
imprinted genes is vitally important in placental function.
Placental expression of genes from two imprinted clusters – Ascl2
and Mest – accounts for a signiﬁcant proportion of the observed
variation in E/P ratio among DNMT1o-deﬁcient placentas. There
was a direct correlation between Mest expression and E/P ratio,
and an inverse correlation between Ascl2 and E/P ratio. Our
methylation studies late in gestation indicate that loss of methy-
lation at the Peg1 DMD is tolerated late in gestation. Furthermore,
Mest expression is predicted to increase with loss of DMD
methylation. In mouse placentas, Mest expression is limited to
tissues derived from extraembryonic mesoderm, in late gestation
it is localized to capillary endothelial cells of the placental
labyrinth. Investigations suggest that Mest is involved in angio-
genic sprouting in labyrinth (Mayer et al., 2000). While a targeted
mutation of Mest was associated with growth retardation and a
reduction in the size of the placenta, the placental phenotype was
not described in detail (Lefebvre et al., 1998). Given that as whole
DNMT1o-deﬁcient placentas have a reduced volume fraction of
the labyrinth, increased Mest expression may be an important
compensatory response in DNMT1o placentas. Our data support
the importance of further investigation to determine the precise
function of imprinted genes in the Mest cluster.
Another important consideration in our ﬁndings is the inter-
action between the fetus and the placenta in determining the
nutrients available to sustain fetal growth. The placenta responds
to fetal signals for increased nutrient demand. While the fetal
signals that inﬂuence placental growth and development are not
well characterized, imprinted genes expressed in the fetus have
been shown to play a role (Constancia et al., 2005). Nevertheless,
the combination of fetal and placental DMD mosaicism in the
Dnmt1D1o model allows us to examine critical relationships
among placental DMD methylation, placental development, and
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